Literature DB >> 16476085

Current co-ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management).

S Donadel-Claeyssens1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16476085     DOI： 10.1111/j.1365-2516.2006.01202.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  18 in total

1.  Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.

Authors:  Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

2.  Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.

Authors:  Lusine Abrahamyan; Andrew R Willan; Joseph Beyene; Marjorie Mclimont; Victor Blanchette; Brian M Feldman
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

3.  Target of prophylaxis in severe haemophilia: more than factor levels.

Authors:  Antonio Coppola; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

Review 4.  Current and evolving features in the clinical management of haemophilia.

Authors:  Antonio Coppola; Massimo Morfini; Ernesto Cimino; Antonella Tufano; Anna M Cerbone; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

5.  Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed.

Authors:  Karin C Berger; Brian M Feldman; Joan Wasserman; Wolfgang Schramm; Victor Blanchette; Kathelijn Fischer
Journal:  Haematologica       Date:  2016-03       Impact factor: 9.941

Review 6.  Low Dose Prophylaxis in Hemophilia Care.

Authors:  Neeraj Sidharthan; Remya Sudevan
Journal:  Indian J Hematol Blood Transfus       Date:  2019-06-15       Impact factor: 0.900

7.  Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

Authors:  Ezio Zanon; Annarita Tagliaferri; Samantha Pasca; Cosimo P Ettorre; Lucia D Notarangelo; Chiara Biasioli; Anna B Aru; Marta Milan; Silvia Linari; Angiola Rocino; Fabio Gagliano; Giovanni Di Minno; Gabriella Gamba; Rita C Santoro; Piercarla Schinco; Marco Marietta; Axel Seuser; Sylvia von Mackensen
Journal:  Blood Transfus       Date:  2019-06-05       Impact factor: 3.443

8.  The influence of prophylactic factor VIII in severe haemophilia A.

Authors:  M Gissel; M F Whelihan; L A Ferris; K G Mann; G E Rivard; K E Brummel-Ziedins
Journal:  Haemophilia       Date:  2011-09-07       Impact factor: 4.287

Review 9.  Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.

Authors:  Hans-Christoph Rossbach
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

Review 10.  Issues in pediatric haemophilia care.

Authors:  Paola Giordano; Massimo Franchini; Giuseppe Lassandro; Maria Felicia Faienza; Roberto Valente; Angelo Claudio Molinari
Journal:  Ital J Pediatr       Date:  2013-04-20       Impact factor: 2.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.